aiqbench analysis
This research addresses the "validation congestion" bottleneck in scientific discovery by introducing PRISMS, a framework that optimizes candidate selection using scalable pairwise rankings rather than data-hungry absolute score regressors. By intelligently escalating queries from low-fidelity heuristics to high-fidelity expert evaluations, the method significantly reduces experimental rounds while maintaining or improving discovery recall. The approach demonstrates how leveraging comparative judgments across multiple levels of expertise can accelerate material and drug design workflows without requiring massive initial training datasets.
Scientific Discovery under Validation Congestion via Multi-Fidelity Pairwise Rankings
arXiv:2610.01827v1 Announce Type: new Abstract: Modern computational methods can now propose candidate molecules, materials, and other scientific designs at an unprecedented scale, creating a validation congestion where candidates are abundant, but experimental capacity to physically evaluate them remains scarce. Discovering novel scientific designs has therefore become increasingly dependent on curation: selecting a small set of promising designs for slow and costly experiments. Existing curation methods typically rely on data-driven regression models that predict absolute scores, but training these models requires substantial experimental data to begin with. Yet, useful curation signals do not have to take the form of absolute measurements, as scientific design discovery is often comparative in nature. Here, we propose that curation can instead be primarily driven by expert pairwise rankings, which are substantially easier to gather. The expertise can come from computational tools or human input of multiple levels of fidelity, ranging from empirical rules of thumb to agentic workflows and experienced scientists. We introduce PRISMS, a framework that uses pairwise rankings from one or more experts, potentially spanning multiple levels of expertise, to identify the most promising candidates without relying on data-hungry regressors. When experts differ in fidelity and cost, PRISMS escalates pairwise queries from lower- to higher-fidelity rankers based on a Fisher-information criterion. In iterative screening that selects designs from fixed drug discovery libraries, PRISMS achieves 50% top-10 discovery recall in ~42% fewer rounds than regression-only active learning, and in ~15% fewer rounds than the ranking-based method with no selective escalation. In optimization that generates new designs without restriction to a predefined library, PRISMS achieves ~18.8% higher hypervolume than the Bayesian optimization baseline.
Abstract:Modern computational methods can now propose candidate molecules, materials, and other scientific designs at an unprecedented scale, creating a validation congestion where candidates are abundant, but experimental capacity to physically evaluate them remains scarce. Discovering novel scientific designs has therefore become increasingly dependent on curation: selecting a small set of promising designs for slow and costly experiments. Existing curation methods typically rely on data-driven regression models that predict absolute scores, but training these models requires substantial experimental data to begin with. Yet, useful curation signals do not have to take the form of absolute measurements, as scientific design discovery is often comparative in nature. Here, we propose that curation can instead be primarily driven by expert pairwise rankings, which are substantially easier to gather. The expertise can come from computational tools or human input of multiple levels of fidelity, ranging from empirical rules of thumb to agentic workflows and experienced scientists. We introduce PRISMS, a framework that uses pairwise rankings from one or more experts, potentially spanning multiple levels of expertise, to identify the most promising candidates without relying on data-hungry regressors. When experts differ in fidelity and cost, PRISMS escalates pairwise queries from lower- to higher-fidelity rankers based on a Fisher-information criterion. In iterative screening that selects designs from fixed drug discovery libraries, PRISMS achieves 50% top-10 discovery recall in ~42% fewer rounds than regression-only active learning, and in ~15% fewer rounds than the ranking-based method with no selective escalation. In optimization that generates new designs without restriction to a predefined library, PRISMS achieves ~18.8% higher hypervolume than the Bayesian optimization baseline.
Machine Learning (cs.LG)
arXiv:2610.01827 [cs.LG]
(or arXiv:2610.01827v1 [cs.LG] for this version)
https://doi.org/10.48550/arXiv.2610.01827 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 357 words
Related coverage

News
Quantum Computing Report · Jun 7, 2026

News
Quantum Computing Report · Jul 25, 2026

RFPs: Neutral - Atom Platform Technologies Grant Programme
fundsforngos.org · Aug 17, 2026

Gemini for Science: AI experiments and tools for a new era of discovery
Google · May 19, 2026